NanJing Pharmaceutical (SHA:600713) raised 500 million yuan via the issue of 180-day bonds to replenish working capital and repay bank loans.
The bonds carry an issuance rate of 1.33% and mature on Nov. 23, according to a Friday filing with the Shanghai bourse.
Industrial Bank served as lead underwriter, with Bank of Nanjing as joint lead underwriter.
Shares of the pharmaceutical company rose 2% in recent trade.
Contemporary Amperex Technology (SHE:300750, HKG:3750) launched the operations of its 3 billion yuan research facility in the southeastern Chinese city of Xiamen, it said in a Thursday press release.The Xiamen Energy Storage Validation Research Institute is the world's largest one-stop testing and validating platform for the sector, according to the battery giant.It allows full-system energy storage containers to undergo testing under extreme environments, CATL said.The world's largest battery maker could use the energy storage validation facility to increase industry quality standards, Chief Scientist Wu Kai said.
Mooreast (SGX:1V3) signed a placement agreement with ZICO Capital to raise around SG$6 million through the placement of up to 44.5 million shares at SG$0.135 per share, according to a Thursday filing with the Singapore Exchange.Shares of the mooring company zoomed over 15% in Friday's late-morning trade.The placement exercise is aimed at strengthening the company's financial position and capital structure, with proceeds allocated for general working capital needs.
KHS's (SGX:ER0) attributable profit to owners zoomed more than 100% in fiscal second half ended March 31 to SG$1.6 million from SG$539,000 a year earlier, according to a Thursday bourse filing.Shares of the property developer were up over 1% in Friday trading.Earnings per share rose to SG$0.0027 compared with SG$0.001 in the year-ago period.Revenue fell 33% year over year to SG$86.8 million from SG$128.8 million.The company declared a final dividend of SG$0.01 per share, taking the total dividend to SG$0.015 per share.